Cannenta is a biotechnology venture developing advanced wound care products. The company has a unique angiogenic factor which can be incorporated in a range of dressing products to accelerate vascularisation in wound beds and thus provide a foundation for effective wound recovery. The technology can be applied to a range of products and indications including treatment of diabetic foot ulcers and other chronic wounds.
Cannenta is working with established manufacturers to incorporate the technology into suitable product carriers and intends to distribute to a global market following a clinical development program.
Company Details
- Employees
- 5
- Address
- Melbourne, Victoria, Au
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.cannenta.com
- HQ
- Melbourne, Victoria
Cannenta Limited Questions
Cannenta Limited's website is http://www.cannenta.com
Cannenta Limited's LinkedIn profile is https://au.linkedin.com/company/cannenta-pty-ltd
Cannenta Limited has
5 employees.
View email and phone details for 5
employees at Cannenta Limited.
Cannenta Limited's industry is
Medical Equipment Manufacturing
Cannenta Limited's top competitors are
Chezleon Pty Ltd,
Neurogen,
Atmo Biosciences,
Haptisim,
Ellen Medical Devices Pty Ltd,
Cannenta Clinic,
Focus Bear,
Quadlytics Inc.,
Cellivate Technologies,
Haemograph.
Cannenta Limited's categories are Medical Equipment Manufacturing
